Pancreatic Cancer Research

ResearcherUniversitat Pompeu FabraActive in the last 2 years

Patricia Sánchez‐Velázquez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7902-3920; OpenAlex author ID A5000067052, A5108147088. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
82
Papers, trials and grants by year

2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 3 papers

Papers 12

  1. Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study. First author DOI 10.1016/j.cireng.2026.800304↗
  2. Response to: "Re: 'Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study'". First author DOI 10.1016/j.cireng.2026.800425↗
  3. Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis. Co-author DOI 10.1093/jnci/djag235↗
  4. Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. Co-author DOI 10.1001/jamasurg.2025.4054↗
  5. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma. Last author DOI 10.1007/s00423-024-03301-3↗
  6. The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial. Co-author DOI 10.1093/bjs/znae236↗
  7. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Co-author DOI 10.1016/j.lanepe.2023.100673↗
  8. Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study. Last author DOI 10.1245/s10434-022-13054-2↗
  9. Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice Co-author DOI 10.1038/s41598-021-85032-9↗
  10. Abdominal Wall Metastasis of Pancreatic Cancer: The Tip of the Iceberg-Case Report. Last author DOI 10.1097/mpa.0000000000001761↗
  11. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial. Co-author DOI 10.1186/s13063-021-05506-z↗
  12. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice. Co-author DOI 10.1038/s41598-020-74947-4↗

Closest collaborators

The 25 strongest of 82 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fernando Burdı́o · 6 shared papers, 2020–2026 · strength 1.00
  2. Laura Guarga · 2 shared papers, 2026 · strength 0.67
  3. Paula Manchon‐Walsh · 2 shared papers, 2026 · strength 0.67
  4. Benedetto Ielpo · 2 shared papers, 2024–2026 · strength 0.47
  5. Elizabeth Pando · 2 shared papers, 2023–2026 · strength 0.35
  6. Julio Cuesta López · 1 shared paper, 2024 · strength 0.28
  7. Tobias Keck · 2 shared papers, 2023–2024 · strength 0.25
  8. Riccardo Casadei · 2 shared papers, 2023–2024 · strength 0.25
  9. Andrea Pietrabissa · 2 shared papers, 2023–2024 · strength 0.25
  10. Bergþór Björnsson · 2 shared papers, 2023–2024 · strength 0.25
  11. Izaak Quintus Molenaar · 2 shared papers, 2023–2024 · strength 0.25
  12. Safi Dokmak · 2 shared papers, 2023–2024 · strength 0.25
  13. Giovanni Carlo Ferrari · 2 shared papers, 2023–2024 · strength 0.25
  14. Thilo Hackert · 2 shared papers, 2023–2024 · strength 0.25
  15. Giovanni Butturini · 2 shared papers, 2023–2024 · strength 0.25
  16. Alessandro Zerbi · 2 shared papers, 2023–2024 · strength 0.25
  17. Alessandro Esposito · 2 shared papers, 2023–2024 · strength 0.25
  18. Bas Groot Koerkamp · 2 shared papers, 2023–2024 · strength 0.25
  19. Ugo Boggi · 2 shared papers, 2023–2024 · strength 0.25
  20. Marc G. Besselink · 2 shared papers, 2023–2024 · strength 0.25
  21. Mohammad Abu Hilal · 2 shared papers, 2023–2024 · strength 0.25
  22. Fabio Ausania · 1 shared paper, 2026 · strength 0.24
  23. Santiago Sánchez-Cabús · 1 shared paper, 2026 · strength 0.24
  24. Juli Busquets · 1 shared paper, 2026 · strength 0.24
  25. Marta Cáceres · 2 shared papers, 2020–2021 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.